Joint Statement on the Death of Former New Jersey Congressman Bob Franks

WASHINGTON, D.C. (Monday, April 12, 2010) - Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood and BioNJ  President Debbie Hart today issued the following statement concerning the death of former U.S. Representative Bob Franks (R-NJ).

“It is with a heavy heart that we mourn the passing Bob Franks, who was a friend and colleague of many years. Through his service to the United States House of Representatives, and more recently as the President of the HealthCare Institute of New Jersey (HINJ), he was a tireless advocate for the health care industry and the patients it serves. He will be remembered for his skillful and thoughtful approach to issues and the sense of humor he brought to his encounters.

“May his legacy and untimely passing serve as an inspiration to those who seek to advance the discovery and development of much needed therapies, treatments and cures. We join with many others in extending thoughts and prayers to Bob’s family.”

Upcoming BIO Events

BIO Intellectual Property Counsels Spring Conference and Committee Meeting
April 19-21, 2010
New Orleans, LA 

Partnering for Global Health
May 3, 2010
Chicago, IL
McCormick Place Convention Center

BIO International Convention
May 3-6, 2010
Chicago, IL
McCormick Place Convention Center

2010 BIO Human Resources Conference
May 4-7, 2010
Chicago, IL 

World Congress on Industrial Biotechnology and Bioprocessing
June 27-30, 2010
Washington, DC

BIO India
September 21 - 22, 2010
Hyderabad, India



BIO’s Livestock Biotechnology Summit
September 28-30, 2010,
Sioux Falls, SD

 About BIO

BIO represents more than 1,200 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.